Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
GxP environments and their relevance to the pharmaceutical industry
Within GxP regulated environments, it is essential to ensure data integrity and traceability of actions throughout the supply chain. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
Consequences of non-compliance with data integrity in the pharmaceutical industry
Non-compliance with GMP regulations, particularly in critical factors such as data integrity and employee identification in manufacturing tasks, can lead to regulatory agencies issuing warning letters and even suspending manufacturing operations. How do you effectively address and prevent these consequences to ensure compliance?
FDA inspections in the pharmaceutical industry
The FDA and EMA share the goal of ensuring compliance with GMP and other applicable regulations in pharmaceutical manufacturing. These entities carry out exhaustive inspections of companies to verify their compliance with established standards. Is your company ready to face the rigorous inspection processes?
Problems using login and password as electronic signature in pharmaceutical manufacturing
The use of the biometric electronic signature not only ensures data integrity and compliance with pharmaceutical regulations, but also solves the problems of inconvenience and loss of time and efficiency of employees.
Electronic signature in pharmaceutical manufacturing: Does it preserve data integrity and comply with regulations?
Password-based electronic signatures are widely used in manufacturing software (MES, ERP) in the pharmaceutical industry, putting at risk data integrity and regulatory compliance. The solution is the biometric electronic signature.
Employees’ identification in the pharmaceutical industry according ALCOA+
The ALCOA+ requirements defined by the FDA establish, among others, the characteristics for correct identification of employees in regulated pharmaceutical processes. The use of biometrics solves the current difficulties in meeting them.
Manufacturing in the pharmaceutical industry: employees’ identification and data integrity
Current employee identification methods in pharmaceutical manufacturing processes cause data integrity breaches in GMP regulated environments, which can be solved with biometrics.
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
